Answers are grounded in this paper and cite their sources.
Prices charged for gene therapies are exceptionally high, even though the key innovations supporting their development have been heavily driven by academic and other research institutions.
No takes yet. Share an insight, caveat, or question.
Vokinger et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: